{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:20:29Z","timestamp":1764994829256,"version":"3.46.0"},"reference-count":24,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Japan Society for Neonatal Health and Development","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,11,28]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Inhaled nitric oxide (iNO) is a known treatment for pulmonary hypertension (PH) associated with bronchopulmonary dysplasia in preterm infants after 7 days of age (postacute phase). However, a consensus regarding the optimal criteria for initiating iNO therapy in this population in the postacute phase is currently lacking. This study, therefore, aimed to identify the criteria for initiating iNO therapy, alongside the associated clinical and echocardiographic findings, in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed a scoping review using the population-concept-context framework following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>PubMed, Embase and the Japanese database \u2018Ichushi\u2019 were systematically searched for relevant articles published between January 2003 and August 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>This study included randomised controlled trials, prospective and retrospective cohort studies, case\u2013control studies and case series on iNO therapy in the postacute phase for preterm infants born before 34 gestational weeks, written in English or Japanese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Data screening, extraction and charting were performed independently, with the characteristics and findings of the included studies subsequently summarised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 10 reports that analysed the data from 10 separate studies. The use of iNO therapy was categorised as prophylactic and rescue purposes. While randomised controlled trials (RCTs) and retrospective analyses indicated the safety of iNO during the postacute phase, the latter highlighted poor prognoses associated with severe cases requiring rescue iNO therapy. Additionally, although echocardiography is currently the primary diagnostic tool for identifying PH in preterm infants, standardised diagnostic criteria are lacking. Further, reports of complications and side effects associated with iNO are rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our exploration of the initiation criteria for iNO revealed that definitive guidelines have not been established. Nonetheless, iNO administration during the postacute phase appeared to be safe and devoid of complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>UMIN000051498.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-087740","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T07:20:18Z","timestamp":1735543218000},"page":"e087740","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born &lt;34 weeks) after 7 days of age"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-7044","authenticated-orcid":false,"given":"Shin","family":"Kato","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Minamitani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miku","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Hospital Organization Kokura Medical Center, Kitakyushu, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2871-4000","authenticated-orcid":false,"given":"Sota","family":"Iwatani","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-9892","authenticated-orcid":false,"given":"Katsuya","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arata","family":"Oda","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Nagano Children's Hospital, Azumino, Nagano, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Hanita","sequence":"additional","affiliation":[{"name":"Center for Perinatal and Neonatal Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujita Health University, Toyoake, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Namba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Research Center for Environmental and Developmental Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nursing, Faculty of Health & Medical Sciences, Kanagawa Institute of Technology, Atsugi, Kanagawa, Japan"},{"name":"Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-7441","authenticated-orcid":false,"given":"Erika","family":"Ota","sequence":"additional","affiliation":[{"name":"Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Research and Development Center for New Medical Frontiers, Department of Advanced Medicine, Division of Neonatal Intensive Care Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"2025120519142849000_14.12.e087740.1","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120519142849000_14.12.e087740.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702273360902"},{"key":"2025120519142849000_14.12.e087740.3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3444"},{"key":"2025120519142849000_14.12.e087740.4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2022.07.057","article-title":"Inhaled Nitric Oxide Therapy in the Post-Acute Phase in Extremely Preterm Infants: A Japanese Cohort Study","volume":"252","author":"Nakanishi","year":"2023","journal-title":"J Pediatr"},{"key":"2025120519142849000_14.12.e087740.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60664-2"},{"key":"2025120519142849000_14.12.e087740.6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41372-022-01582-4","article-title":"Response categorization and outcomes in extremely premature infants born at 22-26 weeks gestation that received inhaled nitric oxide for hypoxic respiratory failure","volume":"43","author":"Boly","year":"2023","journal-title":"J Perinatol"},{"key":"2025120519142849000_14.12.e087740.7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41390-020-0993-4","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia","volume":"89","author":"Hansmann","year":"2021","journal-title":"Pediatr Res"},{"key":"2025120519142849000_14.12.e087740.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061088"},{"key":"2025120519142849000_14.12.e087740.9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamapediatrics.2017.2618","article-title":"Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial","volume":"171","author":"Hasan","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2025120519142849000_14.12.e087740.10","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.105"},{"key":"2025120519142849000_14.12.e087740.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.09.031"},{"key":"2025120519142849000_14.12.e087740.12","first-page":"284","article-title":"Implementation of an Inhaled Nitric Oxide Weaning Protocol and Stewardship in a Level 4 NICU to Decrease Inappropriate Use","volume":"27","author":"Hussain","year":"2022","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2025120519142849000_14.12.e087740.13","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15423","article-title":"Therapeutic response of iNO in preterm infants with hypoxemic respiratory failure","volume":"65","author":"Oka","year":"2023","journal-title":"Pediatr Int"},{"key":"2025120519142849000_14.12.e087740.14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000531586","article-title":"Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia","volume":"120","author":"Fraga","year":"2023","journal-title":"Neonatology"},{"key":"2025120519142849000_14.12.e087740.15","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120519142849000_14.12.e087740.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080298","article-title":"Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol","volume":"14","author":"Minamitani","year":"2024","journal-title":"BMJ Open"},{"key":"2025120519142849000_14.12.e087740.17","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199912000-00007"},{"key":"2025120519142849000_14.12.e087740.18","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025120519142849000_14.12.e087740.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2025120519142849000_14.12.e087740.20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081113","article-title":"The Off-Label Use of Inhaled Nitric Oxide as a Rescue Therapy in Neonates with Refractory Hypoxemic Respiratory Failure: Therapeutic Response and Risk Factors for Mortality","volume":"8","author":"Hsiao","year":"2019","journal-title":"J Clin Med"},{"key":"2025120519142849000_14.12.e087740.21","first-page":"93","article-title":"Inhaled nitric oxide for extremely premature infants \u2013 a multicenter observational study","volume":"34","author":"Iwatani","year":"2022","journal-title":"J Jpn Soc Neonatal Health Dev"},{"key":"2025120519142849000_14.12.e087740.22","first-page":"618","article-title":"The study of extended use of inhaled nitric oxide for infants with hypoxic respiratory failure in non-acute phase and postoperative patients of cardiac surgery","volume":"48","author":"Nakao","year":"2012","journal-title":"J Jpn Soc Perin Neon Med"},{"key":"2025120519142849000_14.12.e087740.23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/apa.16596","article-title":"Inhaled nitric oxide in preterm neonates with preterm prelabour rupture of membranes, a systematic review","volume":"112","author":"Mullaly","year":"2023","journal-title":"Acta Paediatr"},{"key":"2025120519142849000_14.12.e087740.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-087740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:14:41Z","timestamp":1764990881000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-087740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,30]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjopen-2024-087740"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-087740","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}